Gynecological gel

Abstract

The invention discloses gynecological gel, which is mainly prepared from the following raw materials in part by weight: 3 to 20 parts of gallic acid, 5 to 15 parts of himalayan mayapple, 3 to 8 parts of echinacea purpurea extract, 4 to 11 parts of morinda citrifolia extract, 3 to 9 parts of propolis, 1 to 19 parts of Chinese globeflower flower, 8 to 20 parts of rhodiola, 7 to 17 parts of lightyellow sophora root, 3 to 12 parts of realgar, 3 to 8 parts of coptis, 4 to 13 parts of saffron, 2 to 6 parts of vitamin E and 2 to 8 parts of borneol. While curing diseases, the gynecological gel avoids destroying environment of the genital tract, killing beneficial bacteria, arousing medicine resistance and tolerance and wounding human bodies. The gynecological gel disclosed by the invention is more suitable and safer to use, can reduce damage caused by the toxic and side effect of medicines to human bodies, and can improve the immunity of human bodies to protect patients against the toxic and side effect of the medicines.

Description

a gynecological gel technical field The invention relates to a medicine for treating gynecological diseases, more specifically, to a gynecological gel. Background technique The drugs used for gynecological inflammation on the market have the following problems: 1. Almost all the drugs for gynecological inflammation currently on the market will damage the reproductive tract environment and the self-secretion function of the mucous membrane, thereby leading to a decline in the reproductive local immunity and causing The pathogenic bacteria develop drug resistance and drug resistance, and eventually the inflammation recurs; 2. At present, most of the treatments for cervical erosion are physical and surgical methods, which are traumatic to the human body, and women who have undergone cervical surgery cannot give birth naturally. After surgery and physical therapy, the cervical secretion function is destroyed, and the vaginal resistance decreases, which seriously affects sexual...

AI Technical Summary

Problems solved by technology

The drugs used for gynecological inflammation on the market have the following problems: 1. Almost all the drugs for gynecological inflammation currently on the market will damage the reproductive tract environment and the self-secretion function of the mucous membrane, thereby leading to a decline in the reproductive local immunity and causing The pathogenic bacteria develop drug resistance and drug resistance, and eventually the inflammation recurs; 2. At present, most of the treatments for cervical erosion are physical and surgical methods, which are traumatic to the human body, and women who have undergone cervical surgery cannot give birth naturally. After surgery and physical therapy, the cervical secretion function is destroyed, and the vaginal resistance decreases, which seriously affects sexual life and reproductive health